SL Investment

SL Investment is a venture capital firm based in Seoul, South Korea, established in February 2000. The firm focuses on investing in small and medium-sized companies across various sectors, including biotechnology, healthcare, semiconductors, display technologies, renewable energy, and artificial intelligence. SL Investment has a strong track record, having achieved positive financial results for 12 consecutive years without incurring any debt. The firm not only provides capital but also actively supports the management of its portfolio companies to enhance their value. Over the years, SL Investment has successfully facilitated the listing of 31 companies on the KOSDAQ market, helping them to become leaders in their respective industries.

Minju Ahn

Executive Director

Minju Ahn Ph.D

Executive Director and Investment Professional

Jae-Sung Han

Managing Director

Seunghun Lee

CEO

Past deals in Intellectual Property

Panmnesia

Series A in 2024
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.

Novelty Nobility

Series C in 2024
Novelty Nobility is a biotechnology company specializing in the research and development of antibody-based therapeutics targeting novel angiogenesis factors. The company focuses on ophthalmology and oncology, aiming to address unmet medical needs through innovative treatments.

Panmnesia

Seed Round in 2023
Panmnesia is a Korean startup specializing in the development of advanced chip technology. The company is dedicated to creating intellectual property surrounding a technology known as Compute Express Link, which facilitates the pooling of various devices, including AI accelerator chips, processors, and memory, for large data center operators. By enhancing the interoperability of these systems, Panmnesia aims to enable companies to efficiently harness and integrate a diverse array of system components, optimizing performance and resource utilization in high-capacity computing environments.

Solvook

Series A in 2023
Solvook operates a copyright licensing platform for educational materials, offering copyright clearance services. Its cloud-based library provides digital access to various educational resources.

Novelty Nobility

Series B in 2022
Novelty Nobility is a biotechnology company specializing in the research and development of antibody-based therapeutics targeting novel angiogenesis factors. The company focuses on ophthalmology and oncology, aiming to address unmet medical needs through innovative treatments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.